What is Zacks Research's Estimate for MTD Q2 Earnings?

Mettler-Toledo International Inc. (NYSE:MTD - Free Report) - Analysts at Zacks Research lowered their Q2 2025 earnings per share (EPS) estimates for shares of Mettler-Toledo International in a research report issued to clients and investors on Thursday, May 22nd. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings per share of $9.55 for the quarter, down from their previous forecast of $10.18. The consensus estimate for Mettler-Toledo International's current full-year earnings is $42.71 per share. Zacks Research also issued estimates for Mettler-Toledo International's Q4 2026 earnings at $14.08 EPS, FY2026 earnings at $45.83 EPS, Q1 2027 earnings at $10.55 EPS and FY2027 earnings at $54.17 EPS.

Other analysts have also recently issued research reports about the company. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target for the company in a research report on Monday, April 7th. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Evercore ISI increased their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. Robert W. Baird cut their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Finally, Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of "Hold" and a consensus target price of $1,302.11.

Mettler-Toledo International Stock Performance

Shares of MTD traded down $11.03 on Monday, hitting $1,162.16. 11,878 shares of the stock traded hands, compared to its average volume of 149,682. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,546.93. The company has a market capitalization of $24.15 billion, a PE ratio of 28.57, a P/E/G ratio of 3.30 and a beta of 1.40. The business has a 50 day simple moving average of $1,094.61 and a 200 day simple moving average of $1,206.84.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The company had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. During the same period in the previous year, the business earned $8.89 EPS. The firm's revenue was down 4.6% compared to the same quarter last year.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Mettler-Toledo International by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock valued at $3,003,485,000 after acquiring an additional 30,535 shares during the period. Alliancebernstein L.P. boosted its stake in Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock valued at $837,653,000 after acquiring an additional 126,147 shares during the period. Geode Capital Management LLC boosted its stake in Mettler-Toledo International by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after acquiring an additional 11,032 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock valued at $568,032,000 after acquiring an additional 25,272 shares during the period. Finally, T. Rowe Price Investment Management Inc. boosted its stake in Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after acquiring an additional 43,082 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.